Jan Aushadhi Kendras have sold Rs. 5,600 Cr medicines over last 10 years
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
The initiative aims to empower individuals to take proactive steps towards monitoring their health
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Achira is engaged in development and commercialization of PoC medical test kits in India
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Subscribe To Our Newsletter & Stay Updated